RYAN vs. EQH, ERIE, BRP, BRO, WTW, BIP, DOC, RGA, KEY, and FNF
Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Equitable (EQH), Erie Indemnity (ERIE), The Baldwin Insurance Group (BRP), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Brookfield Infrastructure Partners (BIP), Healthpeak Properties (DOC), Reinsurance Group of America (RGA), KeyCorp (KEY), and Fidelity National Financial (FNF). These companies are all part of the "finance" sector.
Ryan Specialty (NYSE:RYAN) and Equitable (NYSE:EQH) are both large-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings.
Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.8%. Equitable pays an annual dividend of $0.88 per share and has a dividend yield of 2.2%. Ryan Specialty pays out 83.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Equitable pays out 27.2% of its earnings in the form of a dividend. Equitable is clearly the better dividend stock, given its higher yield and lower payout ratio.
Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Equitable received 233 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.47% of users gave Equitable an outperform vote while only 38.71% of users gave Ryan Specialty an outperform vote.
84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 92.7% of Equitable shares are owned by institutional investors. 11.1% of Ryan Specialty shares are owned by company insiders. Comparatively, 1.1% of Equitable shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Ryan Specialty has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, Equitable has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500.
Ryan Specialty has a net margin of 9.15% compared to Equitable's net margin of 0.00%. Ryan Specialty's return on equity of 45.87% beat Equitable's return on equity.
Ryan Specialty currently has a consensus price target of $55.67, indicating a potential upside of 1.75%. Equitable has a consensus price target of $40.10, indicating a potential downside of 1.35%. Given Ryan Specialty's higher possible upside, analysts plainly believe Ryan Specialty is more favorable than Equitable.
In the previous week, Ryan Specialty and Ryan Specialty both had 11 articles in the media. Equitable's average media sentiment score of 0.92 beat Ryan Specialty's score of 0.34 indicating that Equitable is being referred to more favorably in the news media.
Summary
Equitable beats Ryan Specialty on 12 of the 19 factors compared between the two stocks.
Get Ryan Specialty News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ryan Specialty Competitors List
Related Companies and Tools
